Toxoplasmosis and pregnancy

Canadian Family Physician

Volumn 60, Issue 4, 2014, Pages 334-336

  Chaudhry, Shahnaz Akhtar ^a   Gad, Nanette ^a   Koren, Gideon ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PYRIMETHAMINE; SPIRAMYCIN; SULFADIAZINE; ANTIINFECTIVE AGENT; ANTIPROTOZOAL AGENT;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLINDNESS; BRAIN DISEASE; CANADA; CLINICAL EFFECTIVENESS; CONGENITAL TOXOPLASMOSIS; COUNSELING; EYE DISEASE; FALSE POSITIVE RESULT; FETUS RISK; HEALTH CARE COST; HEART DISEASE; HUMAN; INFECTION PREVENTION; NEUROLOGIC DISEASE; PREGNANCY; RAW FOOD; SCREENING; TOXOPLASMA GONDII; COMPLICATION; FEMALE; MASS SCREENING; NEWBORN; PREGNANCY COMPLICATIONS, INFECTIOUS; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL; TRANSMISSION; VERTICAL TRANSMISSION;

ANTI-BACTERIAL AGENTS; ANTIPROTOZOAL AGENTS; FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PYRIMETHAMINE; SPIRAMYCIN; SULFADIAZINE; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL;

EID: 84919391796     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Yamada H, Nishikawa A, Yamamoto T, Mizue Y, Yamada T, Morizane M, et al. Prospective study of congenital toxoplasmosis screening with use of IgG avidity and multiplex nested PCR methods. J Clin Microbiol 2011;49(7):2552-6. DOI: 10.1128/JCM.02092-10. Epub 2011 May 4.
2. Jenum PA, Stray-Pedersen B, Melby KK, Kapperud G, Whitelaw A, Eskild A, et al. Incidence of Toxoplasma gondii infection in 35, 940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 1998;36(10):2900-6.
3. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363(9425):1965-76. DOI: 10.1016/S0140-6736 (04) 16412-X.
4. Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect Dis 2012;44(11):805-14. DOI: 10.3109/00365548.2012.693197. Epub 2012 Jul. 25.
5. Bodaghi B, Touitou V, Fardeau C, Paris L, Le Hoang P. Toxoplasmosis: new challenges for an old disease. Eye (Lond) 2012;26(2):241-4. DOI: 10.1038/eye.2011.331. Epub 2012 Jan 6.
6. Kieffer F, Wallon M. Congenital toxoplasmosis. Handb Clin Neurol 2013;112:1099-101. DOI: 10.1016/B978-0-444-52910-7.00028-3.
7. Dubey JP. History of the discovery of the life cycle of Toxoplasma gondii. Int J Parasitol 2009;39(8):877-82.
8. Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet 1999;353(9167):1834-7.
9. Vogel N, Kirisits M, Michael E, Bach H, Hostetter M, Boyer K, et al. Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception. Clin Infect Dis 1996;23(5):1055-60.
10. Gavinet MF, Robert F, Firtion G, Delouvrier E, Hennequin C, Maurin JR, et al. Congenital toxoplasmosis due to maternal reinfection during pregnancy. J Clin Microbiol 1997;35(5):1276-7.
11. McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis 1994;18(1):38-72.
12. Swisher CN, Boyer K, McLeod R. Congenital toxoplasmosis. The Toxoplasmosis Study Group. Semin Pediatr Neurol 1994;1(1):4-25.
13. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999;353(9167):1829-33. DOI: 10.1016/S0140-6736 (98) 08220-8.
14. Berrébi A, Assouline C, Bessières MH, Lathière M, Cassaing S, Minville V, et al. Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol 2010;203(6):552.e1-6. DOI: 10.1016/j.ajog.2010.06.002. Epub 2010 Jul. 15.
15. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 1980;66(5):767-74.
16. Baquero-Artigao F, Del Castillo Martín F, Fuentes Corripio I, Goncé Mellgren A, Fortuny Guasch C, de la Calle Fernández-Miranda M, et al. The Spanish Society of Pediatric Infectious Diseases guidelines for the diagnosis and treatment of congenital toxoplasmosis [article in Spanish]. An Pediatr (Barc) 2013;79(2):116.e1-16. DOI: 10.1016/j.anpedi.2012.12.001. Epub 2013 Jan 23.
17. Stray-Pedersen B. Toxoplasmosis in pregnancy. Baillieres Clin Obstet Gynaecol 1993;7(1):107-37.
18. Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K, et al. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 1997;35(1):174-8.
19. Hedman K, Lappalainen M, Seppäiä I, Mäkelä O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 1989;159(4):736-40.
20. Iqbal J, Khalid N. Detection of acute Toxoplasma gondii infection in early pregnancy by IgG avidity and PCR analysis. J Med Microbiol 2007;56(Pt 11):1495-9. DOI: 10.1099/jmm.0.47260-0.
21. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis 2002;185(Suppl 1):S73-82. DOI: 10.1086/338827.
22. Petersen E, Borobio MV, Guy E, Liesenfeld O, Meroni V, Naessens A, et al. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J Clin Microbiol 2005;43(4):1570-4. DOI: 10.1128/JCM.43.4.1570-1574.2005.
23. Pour Abolghasem S, Bonyadi MR, Babaloo Z, Porhasan A, Nagili B, Gardashkhani OA, et al. IgG avidity test for the diagnosis of acute Toxoplasma gondii infection in early pregnancy. Iran J Immunol 2011;8(4):251-5. DOI: IJIv8i4A8.
24. Merz E. Ultrasound in obstetrics and gynecology. Vol. 1: obstetrics. 2nd ed. New York, NY: Thieme; 2004.
25. Paquet C, Yudin MH. Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can 2013;35(1):78-9.
26. Wallon M, Liou C, Garner P, Peyron F. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ 1999;318(7197):1511-4.
27. Peyron F, Wallon M, Liou C, Garner P. Treatments for toxoplasmosis in pregnancy. Cochrane Database Syst Rev 2000; (2): CD001684. DOI: 10.1002/14651858. CD001684.
28. Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2008;47(4):554-66. DOI: 10.1086/590149.
29. McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis? Mem Inst Oswaldo Cruz 2009;104(2):320-44.
30. Messier V, Lévesque B, Proulx JF, Rochette L, Libman MD, Ward BJ, et al. Seroprevalence of Toxoplasma gondii among Nunavik Inuit (Canada). Zoonoses Public Health 2009;56(4):188-97. DOI: 10.1111/j.1863-2378.2008.01177.x. Epub 2008 Sep. 22.
31. Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 2000;321(7254):142-7.
32. Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, Dubey JP. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol 2010;26(4):190-6. DOI: 10.1016/j.pt.2010.01.009. Epub 2010 Mar. 2.
33. Jones JL, Krueger A, Schulkin J, Schantz PM. Toxoplasmosis prevention and testing in pregnancy, survey of obstetrician-gynaecologists. Zoonoses Public Health 2010;57(1):27-33. DOI: 10.1111/j.1863-2378.2009.01277.x. Epub 2009 Sep. 10.